CAV1 level was decreased in patients with MMD as compared with either patients with intracranial atherosclerotic stroke or healthy subjects, and it was markedly decreased in RNF213 R4810K variant carriers (103). This evidence concerns the gene CAV1 and multiminicore myopathy.